The global interventional cardiology technologies market reached an estimated $12,179 million in 2014. By 2021 it is predicted that this market will have further increased in value to $22,472 million with a compounded annual growth rate of 9.1%. Despite the issues and challenges confronting healthcare providers and players globally, this market remains buoyant and continues to provide improved quality of life for patients suffering from coronary artery disease.
The Future of Coronary Heart Disease Medical Devices to 2021 examines the management of this disease and takes a close look at the technological developments that are driving this market, including detailed geographical analysis and key company profiles.
See details on this report from Smithers Apex at link.